The Influence of Reliable Microbiota Consortia in Probiotic Yogurt on Improving Insulin Sensitivity in Type 2 Diabetes Mellitus Patients
Applied Microbiology · 24.07.2026 · 6 (8) · 86
DOI: 10.3390/applmicrobiol6080086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology, online erschienen am 24.07.2026. Verfasst von Lovita Adriani und 3 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Padjadjaran University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by progressive insulin resistance, impaired glucose regulation, and elevated cardiometabolic risk. Despite the availability of pharmacological therapies, long-term glycemic control remains suboptimal in many patients, highlighting the need for effective adjunctive nutritional strategies. Probiotic yogurt containing well-characterized bacterial consortia has been proposed as one such approach, given its potential to modulate gut microbiota composition, increase short-chain fatty acid (SCFA) production, improve intestinal barrier integrity, and attenuate low-grade systemic inflammation. A narrative review was conducted by searching PubMed, Scopus, and Google Scholar databases using terms related to probiotic yogurt, synbiotic yogurt, insulin sensitivity, T2DM, gut microbiota, Lactobacillus, and Bifidobacterium. Priority was given to randomized controlled trials (RCTs), meta-analyses, and systematic reviews, supplemented by mechanistically relevant preclinical studies. The reviewed evidence indicates that probiotic yogurt generally produces more consistent improvements in long-term metabolic markers, particularly glycated hemoglobin (HbA1c) and lipid profile, than in acute fasting glucose responses. Several trials also report reductions in fasting insulin and the homeostatic model assessment of insulin resistance (HOMA-IR), combined with improvement in the quantitative insulin sensitivity check index (QUICKI), particularly when yogurt is enriched with prebiotic substrates such as inulin and konjac glucomannan. Probiotic yogurt formulated with well-selected microbial consortia may serve as a safe complementary intervention for improving insulin sensitivity and overall metabolic control in T2DM patients.
Förderung
- Padjadjaran University
Zitieren
APA
Adriani, L., Latipudin, D., Mushawwir, A., & Paad, K. M. (2026). The Influence of Reliable Microbiota Consortia in Probiotic Yogurt on Improving Insulin Sensitivity in Type 2 Diabetes Mellitus Patients. Applied Microbiology, 6(8), 86. https://doi.org/10.3390/applmicrobiol6080086
Vancouver
Adriani L, Latipudin D, Mushawwir A, Paad KM. The Influence of Reliable Microbiota Consortia in Probiotic Yogurt on Improving Insulin Sensitivity in Type 2 Diabetes Mellitus Patients. Applied Microbiology. 2026;6(8):86. doi:10.3390/applmicrobiol6080086
BibTeX
@article{Adriani2026,
author = {Adriani, Lovita and Latipudin, Diding and Mushawwir, Andi and Paad, Khairunnisa Mohd},
title = {The Influence of Reliable Microbiota Consortia in Probiotic Yogurt on Improving Insulin Sensitivity in Type 2 Diabetes Mellitus Patients},
journal = {Applied Microbiology},
year = {2026},
volume = {6},
number = {8},
pages = {86},
doi = {10.3390/applmicrobiol6080086}
}
EUVIMED